SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991; 265: 391395.
  • 2
    Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996; 40: 6574.
  • 3
    Dunmore C, Plummer P, Regan G, Mattingly D, Jackson S, Millikan R. Race and differences in breast cancer survival in a managed care population [letter]. J Natl Cancer Inst. 2000; 92: 16901691.
  • 4
    Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992; 326: 10971101.
  • 5
    Johantgen ME, Coffey RM, Harris DR, Levy H, Clinton JJ. Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery. Am J Public Health. 1995; 85: 14321434.
  • 6
    Legorreta AP, Liu X, Parker RG. Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol. 2000; 23: 438441.
  • 7
    McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health. 1987; 77: 15151517.
  • 8
    Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer. 1997; 79: 314319.
  • 9
    Morris CR, Cohen R, Schlag R, Wright WE. Increasing trends in the use of breast-conserving surgery in California. Am J Public Health. 2000; 90: 281284.
  • 10
    Muss HB, Hunter CP, Wesley M, et al. Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience. Cancer. 1992; 70: 24602467.
  • 11
    Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000; 89: 22022213.
  • 12
    Velanovich V, Yood MU, Bawle U, et al. Racial differences in the presentation and surgical management of breast cancer. Surgery. 1999; 125: 375379.
  • 13
    Asian and Pacific Islander Center for Census Information and Services. Our ten years of growth: a demographic analysis on Asian and Pacific Islander Americans. San Francisco: APICCIS, 1992.
  • 14
    MillerBA, KolonelLN, BernsteinL, et al., eds. Racial/ethnic patterns of cancer in the United States, 1988–1992. NIH Pub. No. 96–4104. Bethesda: National Cancer Institute, 1996.
  • 15
    Prehn A, Lin S, Clarke C, et al. Cancer incidence in Chinese, Japanese and Filipinos in the US and Asia, 1988–1992. Union City, CA: Northern California Cancer Center, 1999.
  • 16
    RiesLAG, EisnerMP, KosaryCL, et al., eds. SEER cancer statistics review, 1973–1998. Bethesda: National Cancer Institute, 2001.
  • 17
    FlemingID, CooperJS, HensonDE, et al., eds. American Joint Committee on Cancer staging manual, 5th edition. Philadelphia: J.B. Lippincott, 1997.
  • 18
    PercyC, Van HoltenV, MuirC, eds. International classification of diseases for oncology, 2nd ed. Geneva: World Health Organization, 1990.
  • 19
    Bureau of the Census. Census of population and housing,1990: summary tape file 3 on CD-ROM (machine-readable data files). Washington, DC: Bureau of the Census, 1992.
  • 20
    National Cancer Institute. Physician's data query information for health care professionals, breast cancer. Bethesda: National Cancer Institute, 1995.
  • 21
    SAS for UNIX. Version 6.12. Cary, NC: Statistical Analysis Software, 1996.
  • 22
    Stata 5.0 for Windows 95/NT. College Station, TX: Stata Corporation, 1998.
  • 23
    Kagawa-Singer M, Wellisch DK, Durvasula R. Impact of breast cancer on Asian American and Anglo American women. Cult Med Psychiatry. 1997; 21: 449480.
  • 24
    Lin SS, Phan JC, Lin AY. Breast cancer characteristics of Vietnamese women in the Greater San Francisco Bay Area. West J Med. 2002; 176: 8791.
  • 25
    Lee MM. breast cancer in Asian women [commentary]. West J Med. 2002; 176: 9192.
  • 26
    Maskarinec G, Dhakal S, Yamashiro G, Issell BF. The use of breast conserving surgery: linking insurance claims with tumor registry data. BMC Cancer. 2002; 2: 3. Available from URL: http://www.biomedcentral.com/1471-2407/2/3 [April 5,2002].
  • 27
    Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000; 92: 4247.
  • 28
    Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996; 14: 30093017.
  • 29
    Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg. 1998; 186: 269274.
  • 30
    Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992; 82: 703710.
  • 31
    Hislop TG, Olivotto IA, Coldman AJ, et al. Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Can J Public Health. 1996; 87: 390394.
  • 32
    Samet JM, Hunt WC, Farrow DC. Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology and End Results program, 1983–1986. Cancer. 1994; 73: 23442351.
  • 33
    Facione NC, Giancarlo C, Chan L. Perceived risk and help-seeking behavior for breast cancer: a Chinese-American perspective. Cancer Nurs. 2000; 23: 258267.
  • 34
    Nilchaikovit T, Hill JM, Holland JC. The effects of culture on illness behavior and medical care: Asian and American differences. Gen Hosp Psychiatry. 1993; 15: 4150.
  • 35
    Mo B. Modesty, sexuality and breast health in Chinese-American women. West J Med. 1992; 157: 260264.
  • 36
    Tang TS, Solomon LJ, McCracken LM. Cultural barriers to mammography, clinical breast exam, and breast self-exam among Chinese-American women 60 and older. Prevent Med. 2000; 31: 575583.
  • 37
    Muller JH, Desmond B. Ethical dilemmas in a cross-cultural context: a Chinese example. West J Med. 1992; 157: 323327.
  • 38
    Seow A, Straughan PT, Ng EH, Emmanuel SC, Tan CH, Lee HP. Factors determining acceptability of mammography in an Asian population: a study among women in Singapore. Cancer Causes Control. 1997; 8: 771779.
  • 39
    Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA. 1995; 274: 820825.
  • 40
    Takeuchi DT, Young KNJ. Overview of Asian and Pacific Islander Americans. In: ZaneNWS, TakeuchiDT, YoungKNJ. Confronting critical health issues in Asian and Pacific Islander Americans. Thousand Oaks, CA: Sage, 1994: 321.
  • 41
    Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. CA. 1998; 48: 83107.
  • 42
    Chow LWC, Au GKH, Poon RTP. Breast conservation therapy for invasive breast cancer in Hong Kong: factors affecting recurrence and survival in Chinese women. Aust N Z J Surg. 1997; 67: 9497.
  • 43
    Ng EH, Chiang G, Sng I, Nambiar R, Soo KC. Difficulty of obtaining wide tumour to deep fascial margins in Asian women with breast cancers: implications on treatment and prognosis. Ann Acad Med Singapore. 1996; 23: 241444.
  • 44
    Alagaratnam TT, Wong J. Limitations of mammography in Chinese females. Clin Radiol. 1985; 36: 175177.
  • 45
    Abrams JS, Phillips PH, Friedman MA, Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer. J Natl Cancer Inst. 1995; 87: 18371845.
  • 46
    Abrams J, Chen T, Giusti R. Special communication from the National Cancer Institute: survival after breast-sparing surgery versus mastectomy [news]. J Natl Cancer Inst. 1994; 86: 16721673.
  • 47
    Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet. 1992; 339: 115.
  • 48
    Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet. 1992; 339: 7185.